Bacteriophage therapy

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 649-659

  Sulakvelidze, A ^a   Alavidze, Z ^a   Morris J G , Jr ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; DRUG EFFICACY; DRUG SAFETY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT INDICATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOPHAGES; BIOLOGICAL THERAPY; DISEASE MODELS, ANIMAL; HUMANS;

EID: 0035115171     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.649-659.2001     Document Type: Short Survey

References (77)

1. Bacteriophage therapy of pseudomonas burn wound sepsis
2. The virulent bacteriophage IRA of Salmonella typhimurium: Cloning of phage genes which are potentially lethal for the host cell
3. Bacteriophages show promise as antimicrobial agents
4. Molecular mechanisms of DNA protection from restriction endonucleases in Staphylococcus aureus cells
5. Phage therapy
6. Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective groups
7. Preventive value of dried dysentery, bacteriophage
8. Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential
9. High abundance of viruses found in aquatic environments
10. The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection
11. Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages
12. Remarques sur l'historique de recherches concernant la lyse microbienne transmissible
13. Essais de thérapeutique au moyen du bacteriophage
14. Phage therapy: Past history, and future prospects
15. Bacteriophages and their therapeutic-prophylactic use
16. The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
17. Bacteriophage treatment of suppurative skin infections
18. Sur un microbe invisible antagoniste des bacilles dysentériques
19. Bacteriophage therapy. Review of the principles and results of the use of bacteriophage in the treatment of infections
20. L'action bactericide des eaux de la Jumna et du Gange sur le vibrion du cholera
21. Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases
22. Use of bacteriophages in the treatment of chronic bacterial diseases
23. Efficiency of preventive treatment by phage preparations of children's hospital salmonellosis
24. Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms
25. Bacteriophage therapy. II. The bacteriophage: Its nature and its therapeutic use
26. Immunogenic effect of bacteriophage in patients subjected to phage therapy
27. The transition from host to phage metabolism after T4 infection
28. Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection
29. Bacteriophage therapy of septic complications of orthopaedic surgery
30. Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics
31. Evaluation of efficacy of the use of E. coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants
32. The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura
33. Long-circulating bacteriophage as antibacterial agents
34. Current strategy, and tactics of etiotropic therapy of acute intestinal infections in children
35. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency
36. Regulation of antibody responses: The role of complement and adhesion molecules
37. Bacteriophagotherapy and enterosorbtion in treatment of sepsis of newborns caused by gram-negative bacteria
38. Experience in the therapeutic use of bacteriophage preparations in suppurative surgical infections
39. The efficacy of bacteriophage preparations in treating inflammatory urologic diseases
40. Clinical relevance of antibiotic-induced endotoxin release
41. Use of staphylococcal bacteriophage for therapeutic and preventive purposes
42. Use of bacteriophage filtrates in treatment of suppurative conditions: Report of 300 cases
43. Use of combined phages in suppurative-inflammatory diseases
44. The combined use of specific phages and antibiotics in different infectious allergoses
45. Why are antibiotic resistance genes so resistant to elimination?
46. Bacteriophages and phage therapy in pediatric practice
47. Staphylococcus aureus meningitis: Treatment with specific bacteriophage
48. Pseudomonas aeruginosa bacteriophage in treatment of P. aeruginosa infection in cystic fibrosis patients
49. Discovery and development of new antibiotics: The problem of antibiotic resistance
50. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results
51. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results
52. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in a further 150 cases
53. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases
54. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children
55. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections
56. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986
57. Successful treatment of experimental Escherichia coli infections in mice using phages: Its general superiority over antibiotics
58. Effectiveness of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs
59. The control of experimental E. coli diarrhea in calves by means of bacteriophage
60. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment
61. The efficacy of phages in the prevention of the destruction of pig skin in vitro by Pseudomonas aeruginosa
62. Treatment of experimental infections of mice by bacteriophage
63. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
64. Bacteriophage therapy
65. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn
66. Felix d'Herelle and the origins of molecular biology
67. Correction of intestinal dysbacteriosis with biological preparations in acute leukemia
68. An investigation on the nature of ultramicroscopic viruses
69. Researches on dysentery
70. Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon
71. Donnees actuelles sur les applications therapeutiques des bacteriophages
72. Studies on bacteriophage penetration in patients subjected to phage therapy
73. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures
74. Antimicrobial agents
75. A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases